selective cyclooxygenase-2 inhibitor
The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils
10
Association of maternal pancreatic function and foetal growth in rats treated with DFU, a selective cyclooxygenase-2 inhibitor
9
Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
8
Selective cyclooxygenase-2 inhibitor use and progression of renal function in patients with chronic kidney disease: a single-center retrospective cohort study
6
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
9
EXPERIMENTAL ANTIBACTERIAL ACTIVITY OF SELECTIVE CYCLOOXYGENASE ANTAGONIST
8
Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia
18
Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients
7
The role of cyclooxygenase inhibitors in lipopolysaccharide induced hypophagia in chicken
9
Reduced Risk of Human Lung Cancer by Selective Cyclooxygenase 2 (Cox-2) Blockade: Results of a Case Control Study
7
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase 2
7
Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats
32
Cyclooxygenase 2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees
10
Metabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cells
8
Activation of Guanylate Cyclase-C With Heat-Stable Enterotoxin Fails to Potentiate Celecoxib-Induced Reduction in Colorectal Cancer Cell Growth in Vitro
73
Use of Propolis in Cancer Research
22
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox 2 selective and non selective NSAIDs
16
The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression
18
Calcium Antagonistic Activity of Biophytum Petersianum on Vascular Smooth Muscles of Wistar Rat
5
Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids
11